Genes Chromosomes and Cancer · 1994 · 42 citations · 16 references
MedicineGeneticsOncologyCytogeneticsNeoplasiaTumor ProgressionBorderline Ovarian TumorsCancer CytogeneticsMalignant NeoplasmsMalignant TumorsOvarian CancerOvarian NeoplasiaKaryotypic AbnormalitiesMalignant Epithelial NeoplasmMalignant Ovarian NeoplasmsMalignant Ovarian TumorsNumerical Karyotype AbnormalitiesOvarian Cancer PathogenesisPrimary Ovarian CarcinomaStructural Chromosomal Rearrangements
Simple near-diploid karyotypes in ovarian cancer may indicate either primary alterations related to tumor pathogenesis or abnormalities associated with early tumor progression. We have identified a series of 13 epithelial ovarian tumors with very simple karyotypes. Specifically, these karyotypes were near-diploid and displayed numeric abnormalities alone or combined with one or two structural alterations. The present series includes samples from 10 patients with newly diagnosed adenocarcinomas and 3 patients having borderline malignancies. Recurrent numeric abnormalities were identified and included 9/13 cases (69%) with +12, eight cases (62%) with +8, five cases (38%) with +7, three cases (23%) each with +3 or +5, and two cases (15%) with -X. Five cases in this series displayed certain numeric abnormalities (+12, +7, and -X) as the sole anomalies, thereby qualifying as primary karyotype changes. Of the 6 cases with structural abnormalities, 4 involved chromosome 19, 2 involved chromosome 1, and the remaining abnormalities or translocation partners involved other chromosomes. These findings indicate that some numeric abnormalities are primary karyotype alterations in patients with malignant epithelial ovarian tumors and that chromosome 19 may be preferrentially involved in structural rearrangements during early tumor progression.
16
Birth Defects Original Article Series
Andrew G. Engel · Neurology · 1970 · 902 citations
Medicine, Obstetrics, Pediatrics +11
Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
J H Lee, J. J. Kavanagh, David M. Wildrick et al. · PubMed · 1990 · 192 citations
Life Sciences, Genetics, Oncology +12